Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
Published: (January 13, 2026 at 06:30 AM EST)
1 min read
Source: TechCrunch
Source: TechCrunch
Summary
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.